Why is Alembic Pharma falling/rising?

As of 02-Jul, Alembic Pharmaceuticals Ltd. is currently priced at 989.65, reflecting a decline of 24.95 points or 2.46%. The stock has been underperforming, having fallen for the last two days with a total drop of 5.08%. Today's performance indicates that it has underperformed its sector by 2.54%. The stock's intraday low was Rs 983.3, and while it is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below its 200-day moving average. Additionally, there has been a significant decrease in investor participation, with delivery volume dropping by 42.05% against the 5-day average. Despite a relatively strong ability to service debt and attractive valuations compared to peers, the stock's profits have decreased by 7% over the past year, contributing to its recent decline.
In the broader market context, Alembic Pharmaceuticals has shown a 1.86% increase over the past week, which is notably better than the Sensex's 0.79% gain during the same period. However, over the past month, the stock has decreased by 0.53%, while the Sensex has increased by 2.50%. Year-to-date, Alembic's performance is down 6.56%, contrasting sharply with the Sensex's 6.75% rise. This indicates that while the stock has had some short-term resilience, its overall performance has lagged behind the broader market, reflecting investor concerns about its profitability and market position.